Anti-GULP1 monoclonal antibody

Pre-made anti-GULP1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GULP1/GULP1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0953-Ab-1/ GM-Tg-hg-IP0953-Ab-2Anti-Human GULP1 monoclonal antibodyHuman
GM-Tg-rg-IP0953-Ab-1/ GM-Tg-rg-IP0953-Ab-2Anti-Rat GULP1 monoclonal antibodyRat
GM-Tg-mg-IP0953-Ab-1/ GM-Tg-mg-IP0953-Ab-2Anti-Mouse GULP1 monoclonal antibodyMouse
GM-Tg-cynog-IP0953-Ab-1/ GM-Tg-cynog-IP0953-Ab-2Anti-Cynomolgus/ Rhesus macaque GULP1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0953-Ab-1/ GM-Tg-felg-IP0953-Ab-2Anti-Feline GULP1 monoclonal antibodyFeline
GM-Tg-cang-IP0953-Ab-1/ GM-Tg-cang-IP0953-Ab-2Anti-Canine GULP1 monoclonal antibodyCanine
GM-Tg-bovg-IP0953-Ab-1/ GM-Tg-bovg-IP0953-Ab-2Anti-Bovine GULP1 monoclonal antibodyBovine
GM-Tg-equg-IP0953-Ab-1/ GM-Tg-equg-IP0953-Ab-2Anti-Equine GULP1 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0953-Ab-1/ GM-Tg-hg-IP0953-Ab-2; GM-Tg-rg-IP0953-Ab-1/ GM-Tg-rg-IP0953-Ab-2;
GM-Tg-mg-IP0953-Ab-1/ GM-Tg-mg-IP0953-Ab-2; GM-Tg-cynog-IP0953-Ab-1/ GM-Tg-cynog-IP0953-Ab-2;
GM-Tg-felg-IP0953-Ab-1/ GM-Tg-felg-IP0953-Ab-2; GM-Tg-cang-IP0953-Ab-1/ GM-Tg-cang-IP0953-Ab-2;
GM-Tg-bovg-IP0953-Ab-1/ GM-Tg-bovg-IP0953-Ab-2; GM-Tg-equg-IP0953-Ab-1/ GM-Tg-equg-IP0953-Ab-2
Products NameAnti-GULP1 monoclonal antibody
Formatmab
Target NameGULP1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GULP1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0953-Ag-1Recombinant multi-species GULP1/ CED-6/ CED6 protein


    Target information

    Target IDGM-IP0953
    Target NameGULP1
    Gene ID51454,70676,314543,708601,478834,101100580,615926,100054329
    Gene Symbol and Synonyms3110030A04Rik,5730529O06Rik,CED-6,CED6,GULP,Gulp-2,GULP1
    Uniprot AccessionQ9UBP9,Q5PQS4
    Uniprot Entry NameGULP1_HUMAN,GULP1_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000144366
    Target ClassificationN/A

    The target: GULP1, gene name: GULP1, also named as CED-6, CED6, GULP. The protein encoded by this gene is an adapter protein necessary for the engulfment of apoptotic cells by phagocytes. Several transcript variants, some protein coding and some thought not to be protein coding, have been found for this gene. [provided by RefSeq, Nov 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.